Target Audience:

This webcast is designed to meet the educational needs of ophthalmologists, retina specialists, physician assistants, nurse practitioners, pharmacists, registered nurses, and eye care specialists involved in the treatment and management of patients with age-related macular degeneration (AMD).

Statement of Need/Program Overview

This webcast is intended to improve care of patients with AMD by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Hardware/Software Requirements

A modern web browser is required. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of content. These activities will be marked as such and will provide links to the required software.

CME Provider Privacy Policy and Contact Information

A. Webb Roberts Center for CME of Baylor Health Care System observes privacy and confidentiality of CME information and personal information of CME participants. Third parties receive only aggregated data about CME activities that are relevant to their interests and/or the activities they support. To contact CME Provider, call 1-214-820-2317.

COURSE VIEWING REQUIREMENTS

Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this webcast. During the period December 2, 2013 through December 2, 2014 participants must read all of the material and study the educational webcast.

INSTRUCTIONS FOR COURSE PARTICIPATION
This webcast includes text, graphics, and may include multimedia features. There are no fees for participating in or receiving credit for this webcast.

Click on all of the "medical education webcast" links and review the content presented. You must view all of the content to proceed to the post-test.

Read, complete, and submit answers to the post-test questions and evaluation questions online. You must answer all missed questions until you get them correct.

Participants must receive a test score of 100% in order to proceed to the course evaluation, and they must respond to all evaluation questions to receive a letter of credit.

If needed, you may save your answers and return to complete your course at a later date. You can find your saved course by selecting "Your Course History" on the left navigation bar. Then select "View" next to the course you would like to complete.

LETTER OF CREDIT & TRANSCRIPTS
After submitting the webcast evaluation, you may access your letter of credit by selecting "Your Certificates" on the left navigation bar.

Select "Credit" to view letters of credit onscreen and print from your browser. You may print the letter of credit, but you may not alter the letter of credit.

Your credits will be tallied and may be viewed by selecting "View your transcripts" in the "Your Account" area.

Accreditation:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of A. Webb Roberts Center for CME of Baylor Health Care System and MedNet. The A. Webb Roberts Center for CME of Baylor Health Care System is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

The A. Webb Roberts Center for CME of Baylor Health Care System designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Peter K. Kaiser, MD,
Professor of Ophthalmology,
Cleveland Clinic Lerner College of Medicine,
Staff Surgeon Vitreoretinal Department,
Cole Eye Institute,
Cleveland, OH

Subjects:

  • Age-related Macular Degeneration

Objectives:

  • Select novel approaches in individualizing therapy leading to optimal outcomes for patients with age-related macular degeneration

Financial Disclosure:

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:

Peter K. Kaiser, MD

Consultant: Bayer, Carl Zeiss Meditec, Genentech, Kanghong Biotech, Novartis, Ophthotech, Oraya, Regeneron, Topcon
Speaker's Bureau: Oraya
Research Support: Bayer, Carl Zeiss Meditec, Genentech, Kanghong Biotech, Novartis, Regeneron, Topcon

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:

Kamatham A. Naidu, PhD (MedNet)

No relevant financial relationships

All other individuals in a position to control content have no relevant financial relationships to disclose.